Nexalis outlines 2026 plan as IRX shares jump 35% by Adam Sheldon February 17, 2026February 19, 2026 Nexalis Therapeutics Limited – formerly InhaleRx – has used its first investor presentation since formally changing […]
InhaleRx eyes big pharma deal and ponders product launch through SAS by Steve Jones March 18, 2025March 18, 2025
InhaleRx prepares for pivotal trial in quest to provide relief from breakthrough cancer pain by cannabiz team January 29, 2025January 31, 2025
